Evaluation Value of Blood Biomarker Tests for Efficacy of EGFR-TKI in Advanced NSCLC Treatment

ObjectiveTo analyze the levels of serum CTCs and ctDNA in NSCLC patients receiving first-line EGFR-TKI treatment, and to explore the clinical value of CTCs and ctDNA detection in assessing the efficacy of treatment for advanced lung cancer. MethodsA total of 109 NSCLC patients receiving first-line E...

Full description

Saved in:
Bibliographic Details
Main Authors: Rui FAN, Yonghui WU, Zhan GU, Yanbin PENG, Lixin WANG
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2025-05-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.1017
Tags: Add Tag
No Tags, Be the first to tag this record!